A

Amplitude Ventures

12 employees

Amplitude Venture Capital is an investment firm.

Investor insights

Sectors invested in

Biotechnology15
Health Care10
Therapeutics7
Medical6
Life Science5
Pharmaceutical4
Artificial Intelligence3
Genetics3
Analytics3
biotechnology3
machine learning3
computational chemistry2
protein misfolding2
Biopharma2
Oncology2
HIPAA1
Auto-Immune1
Immunology1
Patient Care1
Chronic Disease1

Funding rounds participated in

$27M sweet spot round size

Most of their 19 investments are in rounds between $7.1M and $50M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Impact Investing
Financial Services
Finance

Date founded

2018

Investments made

T

Tentarix Biotherapeutics, Inc. raised $35M on September 6, 2023

Investors: Versant Ventures, Gilead Sciences, Samsara BioCapital and Amplitude Ventures

E

Evommune raised $50M on April 26, 2023

Investors: Arix Bioscience plc, Andera Partners, SymBiosis, EQT Life Sciences and Amplitude Ventures

R

Radiant Biotherapeutics raised $8M on April 25, 2023

Investors: Amplitude Ventures

C

Congruence Therapeutics raised $15M on March 6, 2023

Investors: OrbiMed Advisors and Amplitude Ventures

D

DrugBank raised $7.1M on April 11, 2022

Investors: Brightspark Ventures, BoxOne Ventures, Theodorus Investment Funds and Amplitude Ventures

C

Celsius Therapeutics raised $83M on March 24, 2022

Investors: Heritage Physician Networks, 苏州凯风正德投资管理有限公司, Catalio Capital Management, Third Rock Ventures, Section 32, GV, Casdin Capital, LLC, Fast Track Initiative and Amplitude Ventures

C

Congruence Therapeutics raised $50M on February 8, 2022

Investors: OrbiMed Advisors, Driehaus Capital Management LLC, Lumira Ventures and Amplitude Ventures

I

InVivo AI raised $7M on December 15, 2021

Investors: Phoenix Venture Partners LLC, Air Street Capital and Amplitude Ventures

P

Prilenia raised $43M on November 3, 2021

Investors: Sectoral Asset Management, Sands Capital Management, Morningside Venture Partners, Forbion, ALS Investment Fund and Amplitude Ventures

T

Thryv Therapeutics Inc. raised $19M on August 10, 2021

Investors: Lumira Ventures and Amplitude Ventures

FAQ